CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Lowenthal Richard E President and CEO | Grant or award · Stock option (right to buy) | +880,000 | 880,000 | ||
| 2024-01-02 | Lowenthal Richard E President and CEO | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2024-01-02 | Karas Eric Chief Commercial Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-01-02 | Tanimoto Sarina Chief Medical Officer | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2024-01-02 | Tanimoto Sarina Chief Medical Officer | Grant or award · Stock option (right to buy) | +880,000 | 880,000 | ||
| 2024-01-02 | Dorsey Brian Chief Operating Officer | Grant or award · Stock option (right to buy) | +350,000 | 350,000 | ||
| 2024-01-02 | Chakma Justin Chief Business Officer | Grant or award · Stock option (right to buy) | +350,000 | 350,000 | ||
| 2024-01-02 | Scott Kathleen D. Chief Financial Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-01-02 | Fitzpatrick Alexander A Chief Legal Officer | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2023-09-29 | Fitzpatrick Alexander A Chief Legal Officer | Purchase | +46,258 | $3.78 | $175K | 89,227 |
| 2023-09-28 | Fitzpatrick Alexander A Chief Legal Officer | Purchase | +40,000 | $3.62 | $145K | 42,969 |
| 2023-09-21 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +2,508,691 | $2.97 | $7.5M | 8,365,465 |
| 2023-09-21 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +191,309 | $3.83 | $733K | 8,556,774 |
| 2023-09-01 | Shawver Laura Director | Exercise or conversion 10b5-1 | +2,997 | $1.27 | $4K | 213,343 |
| 2023-09-01 | Shawver Laura Director | Exercise or conversion 10b5-1 | +97,003 | $1.27 | $123K | 310,346 |
| 2023-09-01 | Shawver Laura Director | Sale 10b5-1 | −100,000 | $7.71 | $771K | 210,346 |
| 2023-09-01 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −2,997 | 0 | ||
| 2023-09-01 | Shawver Laura Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −97,003 | 55,235 | ||
| 2023-08-29 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +3,750,000 | $6.20 | $23.3M | 5,856,774 |
| 2023-08-29 | ORBIMED ADVISORS LLC Director | Purchase | +500,000 | $6.20 | $3.1M | 8,019,187 |
Page 20 of 31 · 602 trades